REGISTERED NUMBER: 14396246 (England and Wales)

Financial Statements for the Year Ended 31 March 2026

for

Anzu Family Medical Ltd

Page

Balance Sheet

1

FIXED ASSETS

670

1,005

CURRENT ASSETS

43,998

34,592

CREDITORS

Amounts falling due within one year

(13,966

)

(13,139

)

NET CURRENT ASSETS

30,032

21,453

TOTAL ASSETS LESS CURRENT LIABILITIES

30,702

22,458

CAPITAL AND RESERVES

30,702

22,458

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Anzu Family Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

14396246

Registered office:

Flannagans, Unit 3A Evolution

Wnyard Avenue

Wynyard Business Park

Billingham

Cleveland

TS22 5TB

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2025 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 4 November 2026 and were signed on its behalf by:

Dr Ryan Tewari - Director